AGTR1 and metabolic disease: Because of these responses, the ACE2/Ang 1–7/Mas axis counteracts the deleterious effect of ACE/Ang II/AT1R axis and has been investigated as a target for reducing metabolic diseases and CVD (Rabelo et al., 2011; Ramalingam et al., 2017).